Enabled Nanotechnology drug delivery is Driven by Advanced Targeting Capabilities
Nanotechnology-enabled drug delivery utilizes nanoscale particles, nanoparticles, nanotubes, or nanoemulsions for more efficient and targeted drug delivery applications. Nanocarriers allow for passive or active targeting of drugs to specific cells and tissues. Certain nanoparticles can escape the typical defenses of the immune system, allowing them to remain in circulation longer and target tumors and areas of inflammation more effectively. The ability of nanocarriers to encapsulate both hydrophobic and hydrophilic drug molecules has significantly enhanced the solubility and stability of some drug compounds.
Global nanotechnology drug delivery market is estimated to be valued at USD 97.10 Bn in 2024 and is expected to reach USD 203.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031
Growing demand for targeted drug delivery and site-specific action of drugs is boosting the nanotechnology drug delivery market. Rising Nanotechnology drug delivery Market Demand for biologics and protein & peptide therapeutics along with increasing R&D investments by pharmaceutical companies are fueling the market growth. Technological advancements have led to development of innovative drug delivery systems for global expansion of the nanotechnology drug delivery market across developed as well as emerging economies.
Get More Insights On- Nanotechnology drug delivery Market
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian